Lori Luchtman-Jones, MD
- Medical Director, Hemostasis & Thrombosis Laboratory
- Director, Thrombosis Research
- Medical Director, Division of Hematology
- Professor, UC Department of Pediatrics
- lori.luchtman-jones@cchmc.org
- Board Certified
About
Biography
I’m a board-certified pediatric hematologist-oncologist, or blood doctor. Early in my career I worked as an oncologist and bone marrow transplant doctor. I now specialize in pediatric hematology with a focus on hemostasis and thrombosis (blood clotting disorders). I am also a member of the Cerebrovascular Program at Cincinnati Children’s, where I work to improve the diagnosis and management of pediatric stroke.
I chose my career because I love children — especially adolescents and young adults. I am inspired by the honesty and courage of my patients. Having to take medicine every day or having limitations on activity or endurance is difficult. However, I believe that people want to be healthy and strong, and by working together we can find a way forward. When patients, families and medical staff work together, the impossible can become possible.
I am always looking for ways to improve outcomes. In addition to my clinical practice, I conduct research and direct a clinical laboratory where we look for solutions to bleeding and clotting problems. My team and I are trying to understand the connections between diseases like inflammatory disorders or sickle cell anemia and clotting. We also look for better ways to diagnose problems with platelet function.
Outside of the hospital, I enjoy cooking, growing herbs and reading mystery books. I also like to rehab old houses.
MD: University of California, San Diego, San Diego, CA, 1987.
Residency: Pediatrics, University of California San Diego School of Medicine, San Diego, CA, 1990.
Fellowship: Pediatric Hematology Oncology, Washington University in St. Louis School of Medicine/St. Louis Children’s Hospital, St. Louis, MO, 1994.
Certification: Pediatrics 1990; Pediatric Hematology Oncology, 1996 - present.
Interests
Pediatric hematology: thrombosis; hemostasis; stroke
Services and Specialties
- Cancer and Blood Diseases Institute
- Cancer and Blood Diseases Clinical Labs
- Cardio-Oncology Program
- Cerebrovascular Disease and Stroke
- Classical Hematology
- Hemophilia and Bleeding Disorders
- Hemostasis and Thrombosis
- Immune Deficiency and Histiocytosis
- Thrombosis
- Genetics and Genomics Diagnostic Laboratory
Interests
Thrombosis; stroke
Research Areas
Additional Languages
German, Spanish
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Comment on: "Comment on: Bivalirudin During Thrombolysis With Catheter-Directed tPA in a Heparin-Refractory Patient: A Case Report ": The Promise of Dilute Thrombin Time and Drug-Calibrated Assays for Improved Bivalirudin Monitoring. Pediatric Blood and Cancer. 2025; 72:e31418.
Impact of inflammation and steroids on anti-coagulation in children supported on a ventricular assist device. Journal of Artificial Organs. 2024; 27:368-374.
Bivalirudin Monitoring By Dilute Thrombin Time Is Cost-Efficient in Pediatric ECMO Patients. Blood. 2024; 144:5018.
Seeing haemoglobin SC: Challenging the misperceptions. British Journal of Haematology. 2024; 205:404-405.
Evaluation, analysis, and reporting of medication adherence for clinical trials of anticoagulants in children: guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 2024; 22:2081-2092.
Bivalirudin Monitoring in Pediatric Ventricular Assist Device and Extracorporeal Membrane Oxygenation: Analysis of Single-Center Retrospective Cohort Data 2018-2022. Pediatric Critical Care Medicine. 2024; 25:e328-e337.
Barriers to medication adherence in children, adolescents, and young adults prescribed anticoagulation. Pediatric Blood and Cancer. 2023; 70:e30076.
Use of a Calibrated, Drug-Specific DTT Assay to Improve Bivalirudin Monitoring in Pediatric Extracorporeal Membrane Oxygenation (ECMO). Blood. 2022; 140:8518-8519.
Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium. Research and Practice in Thrombosis and Haemostasis. 2022; 6:e12793.
Results of an international survey on adherence with anticoagulation in children, adolescents, and young adults: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 2022; 20:1720-1728.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey